Today: 16 May 2026
NatWest shares steady as £750m buyback starts, with UK inflation next on the radar
17 February 2026
1 min read

NatWest shares steady as £750m buyback starts, with UK inflation next on the radar

London, Feb 17, 2026, 08:03 GMT — Regular session

  • NatWest was unchanged at 607.8 pence in early trading, holding steady after jumping sharply on Monday.
  • The lender kicked off a share buyback program worth up to £750 million, with plans to continue it through 2027.
  • UK inflation figures land Feb. 18—next up for traders eyeing rate cuts and their impact on bank shares.

NatWest Group Plc’s stock held steady at 607.8 pence in early London action Tuesday. The bank has begun its latest share buyback programme.

This step stands out right now: buybacks hand cash straight to shareholders and help boost earnings per share by pulling down the share count — crucial for UK bank trades, especially when there’s not much else driving things day to day.

It comes as investors shift gears in the banking sector following a rocky run for European financial stocks. NatWest and other lenders bounced back in the last session.

NatWest, in a Feb. 16 regulatory filing, outlined a share buyback programme capped at £750 million, with an end date set for Jan. 15, 2027. If trading is disrupted, that deadline could stretch to Feb. 12, 2027. The bank tapped UBS AG, London Branch, to handle the purchases following non-discretionary instructions. NatWest plans to cancel all repurchased shares.

NatWest shares rallied roughly 4.8% Monday, finishing at 607.8 pence—an advance that beat the wider market. Still, the stock hasn’t climbed back to its early-February highs.

Broker sentiment has shifted a bit, with some analysts getting more upbeat. Robert Noble at Deutsche Bank described NatWest’s latest results as a “decent beat.” Still, he pointed out the low end of the bank’s 2026 revenue guidance “may concern some,” according to a report out Monday. Proactiveinvestors UK

This week, broader macro trends could overshadow individual bank news. According to a Reuters poll out Monday, most economists anticipate the Bank of England will lower the Bank Rate by 25 basis points—down a quarter-point—on March 19. Deutsche Bank’s Sanjay Raja summed it up: “We stick to our call for the next Bank Rate cut to come in March.” Reuters

UK consumer price inflation figures land Wednesday, Feb. 18, at 0700 GMT—a data drop traders are eyeing to pressure-test those rate-cut bets.

There’s a clear risk here: hotter-than-expected inflation can swiftly knock rate-cut bets off course, sending bank stock valuations lower. And if volatility jumps, buybacks could slow or even pause — not exactly a morale booster for investors.

NatWest’s focus right now? Signs that its buyback is actually moving the needle, plus the latest inflation data due Wednesday—which could sway market expectations for UK rates. The Bank of England sets rates again on March 19.

Stock Market Today

  • Soros Fund Management Buys Berkshire Hathaway Stock After Buffett's Departure
    May 15, 2026, 6:02 PM EDT. George Soros's firm, Soros Fund Management, increased its equity holdings value in Q1 despite a declining market. The fund notably purchased shares in Berkshire Hathaway following Warren Buffett's exit. Soros also raised stakes in tech giants Nvidia and Apple, reflecting a strategic emphasis on growth and resilience amid market volatility.

Latest articles

Tonix Pharma Stock Gains After Antibody News, 2027 Lyme Trial Planned

Tonix Pharma Stock Gains After Antibody News, 2027 Lyme Trial Planned

15 May 2026
Tonix Pharmaceuticals filed new Phase 1 modeling data showing its experimental Lyme disease antibody, TNX-4800, could maintain serum levels above a proposed protective threshold for six months with a two-dose regimen. Shares rose $1.65 to $15.74 Friday. The company plans a Phase 2 trial in 2027, pending FDA agreement. No Lyme vaccine is currently available in the U.S.
AXT delays annual meeting to June after AI-driven stock jump

AXT delays annual meeting to June after AI-driven stock jump

15 May 2026
AXT adjourned its 2026 annual meeting after failing to reach a quorum, rescheduling for June 4. The company seeks shareholder approval to raise authorized common shares to 120 million from 70 million. Shares closed at $123.78, up 7.65%, after a volatile session. China’s export controls on indium phosphide remain a key risk for AXT’s business.
Hyperscale Data moves higher after $5M tender, all eyes on 10-Q

Hyperscale Data moves higher after $5M tender, all eyes on 10-Q

15 May 2026
Hyperscale Data plans a tender offer to buy up to $5 million of Class A shares at $0.21 each, above the last GPUS trade at $0.146. The company reported a preliminary first-quarter net loss of about $30 million on revenue of $44 million and filed a late notice for its Form 10-Q. The offer is pending board and regulatory approval.
Seek Limited share price drops as ASX:SEK flags Employment Hero exit and tightens FY26 outlook
Previous Story

Seek Limited share price drops as ASX:SEK flags Employment Hero exit and tightens FY26 outlook

Strike threat at Futamura: Wigton packaging workers reject 1.2% pay rise, set vote
Next Story

Strike threat at Futamura: Wigton packaging workers reject 1.2% pay rise, set vote

Go toTop